JB/PUT/MERCK & CO./120/0.0333/20.09.24 | Market Closed - Swiss Exchange 08:50:00 06/06/2024 pm IST | ||
| 0.06 CHF | -14.29% |
|
| 1 month | -33.33% | ||
| 3 months | -60.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 06/24/06 | 0.06 | -14.29% |
| 05/24/05 | 0.07 | -12.50% |
| 03/24/03 | 0.08 | -20.00% |
Delayed Quote Swiss Exchange
Last update June 06, 2024 at 08:50 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | MERCK & CO., INC. |
| Issuer | Bank Julius Bär |
| MRKGJB | |
| ISIN | CH1311830272 |
| Date issued | 08/01/2024 |
| Strike | 120 $ |
| Maturity | 20/09/2024 (102 Days) |
| Parity | 30 : 1 |
| Emission price | 0.26 CHF |
| Emission volume | N/A |
| Settlement | cash |
| Currency | CHF |
Technical Indicators
| Highest since issue | 0.24 CHF |
|---|---|
| Lowest since issue | 0.06 CHF |
| Spread | 0.01 CHF |
| Spread % | 14.29% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.5
USD
Average target price
142.7
USD
Spread / Average Target
+8.51%
- Stock Market
- Warrants
- MRKGJB Warrant
